Literature DB >> 28575490

Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: a multicentre randomized efficacy and safety trial (ULTRA-FAST trial).

Kenichiro Yamagata1, Dan Wichterle2,3, Tomáš Roubícek4, Patrik Jarkovský3, Yuriko Sato5, Takamichi Kogure6, Petr Peichl1, Petr Konecný1, Helena Jansová3, Pavel Kucera4, Bashar Aldhoon1, Robert Cihák1, Yoichi Sugimura5, Josef Kautzner1.   

Abstract

Aims: Complications of catheter ablation for atrial fibrillation (AF) are frequently related to vascular access. We hypothesized that ultrasound-guided (USG) venipuncture may facilitate the procedure and reduce complication rates. Methods and results: We conducted a multicentre, randomized trial in patients undergoing catheter ablation for AF on uninterrupted anticoagulation therapy. The study enrolled consecutive 320 patients (age: 63 ± 8 years; male: 62%) and were randomized to USG or conventional venipuncture in 1:1 fashion. It was prematurely terminated due to substantially lower-than-expected complication rates, which doubled the population size needed to maintain statistical power. While the complication rates did not differ between two study arms (0.6% vs. 1.9%, P = 0.62), intra-procedural outcome measures were in favour of the USG approach (puncture time, 288 vs. 369 s, P < 0.001; first pass success, 74% vs. 20%, P < 0.001; extra puncture attempts 0.5 vs. 2.1, P < 0.001; inadvertent arterial puncture 0.07 vs. 0.25, P < 0.001; unsuccessful cannulation 0.6% vs. 14%, P < 0.001). Though these measures varied between trainees (49% of procedures) and expert operators, between-arm differences (except for unsuccessful cannulation) were comparably significant in favour of USG approach for both subgroups. Conclusions: Ultrasound-guided puncture of femoral veins was associated with preferable intra-procedural outcomes, though the major complication rates were not reduced. Both trainees and expert operators benefited from the USG strategy. (www.clinicaltrials.gov ID: NCT02834221).

Entities:  

Mesh:

Year:  2018        PMID: 28575490     DOI: 10.1093/europace/eux175

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  10 in total

1.  Catheter directed thrombolytic therapy and aspiration thrombectomy in intermediate pulmonary embolism with long term results.

Authors:  Zoltan Ruzsa; Zoltan Vámosi; Balázs Berta; Balázs Nemes; Károly Tóth; Nándor Kovács; Endre Zima; Dávid Becker; Béla Merkely
Journal:  Cardiol J       Date:  2020-04-24       Impact factor: 2.737

2.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

Review 3.  The Impact of Advances in Atrial Fibrillation Ablation Devices on the Incidence and Prevention of Complications.

Authors:  Fehmi Keçe; Katja Zeppenfeld; Serge A Trines
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

4.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

Review 5.  Catheter Ablation of Atrial Fibrillation in Heart Failure: from Evidences to Guidelines.

Authors:  Arianna Cirasa; Carmelo La Greca; Domenico Pecora
Journal:  Curr Heart Fail Rep       Date:  2021-04-04

6.  Meta-analysis of ultrasound-guided vs conventional vascular access for cardiac electrophysiology procedures.

Authors:  Tom Kai Ming Wang; Michael Tzu Min Wang; Andrew Martin
Journal:  J Arrhythm       Date:  2019-09-16

Review 7.  Ultrasound-guided versus anatomic landmark-guided vascular access in cardiac electrophysiology procedures: A systematic review and meta-analysis.

Authors:  Konstantinos Triantafyllou; Christos D Karkos; Nikolaos Fragakis; Antonios P Antoniadis; Magdalini Meletidou; Vassilios Vassilikos
Journal:  Indian Pacing Electrophysiol J       Date:  2022-02-07

8.  Near zero vascular complications using echo-guided puncture during catheter ablation of arrhythmias: A retrospective study and literature review.

Authors:  Pier Luigi Pellegrino; Antonio Di Monaco; Francesco Santoro; Massimo Grimaldi; Girolamo D'Arienzo; Grazia Casavecchia; Riccardo Ieva; Matteo Di Biase; Massimo Iacoviello; Natale Daniele Brunetti
Journal:  J Arrhythm       Date:  2022-04-28

9.  Femoral venous hemostasis after atrial fibrillation ablation: Is figure-of-eight suture the way to go?

Authors:  Syeda Atiqa Batul; Rakesh Gopinathannair
Journal:  Indian Pacing Electrophysiol J       Date:  2017-08-31

10.  Safety of Catheter Ablation of Atrial Fibrillation Under Uninterrupted Rivaroxaban Use.

Authors:  Márcio Augusto Silva; Guilherme Muller de Campos Futuro; Erick Sessa Merçon; Deborah Vasconcelos; Rovana Silva Agrizzi; Jorge Elias Neto; Ricardo Kuniyoshi
Journal:  Arq Bras Cardiol       Date:  2020-03       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.